These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10367295)
1. Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice. Steil AA; Teixeira CF; Jancar S Prostaglandins Other Lipid Mediat; 1999 Jan; 57(1):35-48. PubMed ID: 10367295 [TBL] [Abstract][Full Text] [Related]
2. Modulation by lipid mediators of immune complex-induced lung inflammation in mice. Steil AA; Tavares de Lima W; Jancar S Eur J Pharmacol; 1998 Nov; 361(1):93-9. PubMed ID: 9851546 [TBL] [Abstract][Full Text] [Related]
3. Release of eicosanoids in rat peritoneal cavity during the Arthus reaction. Effect of the PAF-antagonist BN-52021 and indomethacin. Jancar S; Braquet P; Sirois P Int J Immunopharmacol; 1989; 11(2):129-32. PubMed ID: 2539337 [TBL] [Abstract][Full Text] [Related]
4. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats. Rocha FA; Andrade LE; Russo M; Jancar S J Lipid Mediat Cell Signal; 1997 May; 16(1):1-10. PubMed ID: 9101418 [TBL] [Abstract][Full Text] [Related]
5. Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin. Mózes T; Zijlstra FJ; Heiligers JP; Tak CJ; Ben-Efraim S; Bonta IL; Saxena PR Br J Pharmacol; 1991 Nov; 104(3):691-9. PubMed ID: 1797328 [TBL] [Abstract][Full Text] [Related]
6. PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis. Jancar S; Sirois MG; Carrier J; Braquet P; Sirois P Inflammation; 1991 Oct; 15(5):347-54. PubMed ID: 1757122 [TBL] [Abstract][Full Text] [Related]
7. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021. Jancar S; Braquet P; Sirois P Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218 [TBL] [Abstract][Full Text] [Related]
8. Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs. Olson NC; Joyce PB; Fleisher LN Am J Physiol; 1990 Jun; 258(6 Pt 2):H1674-86. PubMed ID: 2163217 [TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Quinn JV; Slotman GJ Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269 [TBL] [Abstract][Full Text] [Related]
11. Involvement of eicosanoids and PAF in immune-complex alveolitis. Tavares-de-Lima W; Teixeira CF; Sirois P; Jancar S Braz J Med Biol Res; 1989; 22(6):745-8. PubMed ID: 2620187 [TBL] [Abstract][Full Text] [Related]
12. Lipid mediator production in acute and chronic pancreatitis in the rat. Zhou W; Levine BA; Olson MS J Surg Res; 1994 Jan; 56(1):37-44. PubMed ID: 8277767 [TBL] [Abstract][Full Text] [Related]
13. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. Piper PJ; Stewart AG Br J Pharmacol; 1986 Jul; 88(3):595-605. PubMed ID: 3091131 [TBL] [Abstract][Full Text] [Related]
14. Aggregating and prostanoid-releasing effects of platelet-activating factor and leukotrienes on human polymorphonuclear leukocytes and platelets. Dahl ML Int Arch Allergy Appl Immunol; 1985; 76(2):145-50. PubMed ID: 2981776 [TBL] [Abstract][Full Text] [Related]
15. Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor. Okamoto H; Iwahisa Y; Terasawa M Agents Actions; 1992 Mar; 35(3-4):149-58. PubMed ID: 1388318 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells. Rodríguez M; Márquez S; Montero O; Alonso S; Frade JG; Crespo MS; Fernández N Biochem Pharmacol; 2016 Feb; 102():78-96. PubMed ID: 26673542 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. Doebber TW; Wu MS; Biftu T J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900 [TBL] [Abstract][Full Text] [Related]
18. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Kolaczkowska E; Shahzidi S; Seljelid R; van Rooijen N; Plytycz B Inflammation; 2002 Apr; 26(2):61-71. PubMed ID: 11989789 [TBL] [Abstract][Full Text] [Related]
19. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin. Hellewell PG; Williams TJ J Immunol; 1986 Jul; 137(1):302-7. PubMed ID: 2940300 [TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes. Wallace JL; MacNaughton WK Eur J Pharmacol; 1988 Jun; 151(1):43-50. PubMed ID: 2843390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]